Navigation Links
Genomic Health Announces First Quarter 2011 Financial Results and Business Progress
Date:5/3/2011

enues

352

963Total revenues

49,810

41,229OPERATING EXPENSES:Cost of product revenues

9,059

8,966Research and development

10,091

7,793Selling and marketing

20,536

18,016General and administrative

10,356

8,327Total operating expenses

50,042

43,102Loss from operations

(232)

(1,873)Interest and other income

65

108Interest and other expense

50

21Loss before income taxes

(217)

(1,786)Income tax provision

69

146Net loss

$
(286)

$ (1,932)Basic and diluted net loss per share

$   (0.01)

$   (0.07)Shares used to compute basic and diluted net loss per share

29,104

28,636Genomic Health, Inc.Condensed Consolidated Balance Sheets(in thousands)As ofMarch 31,

December 31, 2011

2010(Unaudited)Cash and cash equivalents

$   18,157

$
31,183Short-term investments

45,435

45,635Accounts receivable, net

16,262

14,306Prepaid expenses and other current assets

7,307

6,541Total current assets

87,161

97,665Long-term investments

12,982

-Property and equipment, net

10,685

10,345Restricted cash

110

608Long-term equity investments

2,770

500Other assets

1,706

1,743Total assets

$ 115,414

$
,861Accounts payable

$
4,737

$
3,968Accrued expenses and other current liabilities

14,821

16,305Deferred revenues

2,466

2,821Other liabilities

1,537

1,657Stockholders’ equity

91,853

86,110Total liabilities and stockholders’ equity

$ 115,414

$
,861The condensed consolidated balance sheet at December 31, 2010 has been derived from the audited consolidated financial statements at that date included in the Company's
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting
2. Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1%
3. Genomic Health Presents Multiple International Studies Demonstrating Worldwide Value of Oncotype DX® Breast Cancer Test
4. Reminder Webcast Alert: Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
5. Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
6. Everist Genomics Laboratory Receives Approval From U.S. Regulatory Authorities For High Complexity Clinical Testing
7. Researchers use genomics to investigate TB outbreak
8. Transgenomic to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 17
9. Genomic Health Announces Results from Biomarker Discovery Program Utilizing Next-Generation Sequencing to Compare Normal and Tumor Breast Tissue
10. Sigma Life Science Collaborates with Cofactor Genomics to Develop Publically Available Rat Genome Database
11. Four Community Hospitals Join DNA Directs Genomic Medicine Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 Today, TiFiber, Inc. ... production facility and future company headquarters in Fort ... new materials that safely and effectively control dangerous ... of its historic, strong support for manufacturing, but ... leading edge, technology-based companies such as TiFiber. ...
(Date:12/19/2014)... Biddeford, ME (PRWEB) December 18, 2014 ... founding director of the Center for Excellence in the ... of New England, has been selected as a member ... He is the first neuroscientist from Maine to receive ... a nonprofit organization supported entirely by the Dana Foundation. ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... to the rising ageing population and technological innovations ... and nutraceutical industries are catalysing the growth of ... @ http://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html , Scope of Report ... as well as new entrants/smaller firms to gauge ...
Breaking Biology Technology:Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4
... September 7, 2011 Debiopharm ... that focuses on serious medical conditions and ... a privately-held, biopharmaceutical company dedicated to the ... treat cancer, have entered into an exclusive ...
... Mich. Researchers at Michigan State University have unraveled ... up nuclear waste and other toxic metals. Details ... are published in the current issue of the ... implications could eventually benefit sites forever changed by nuclear ...
... ThermoGenesis Corp. (NASDAQ: KOOL ), a leading supplier ... today it will report financial results for the fiscal fourth quarter ... 2011. Company,s Conference Call and Webcast ... 12, 2011 at 2:00 PM Pacific (5:00 PM Eastern) to review ...
Cached Biology Technology:Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T 2Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T 3Microbes generate electricity while cleaning up nuclear waste 2ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2011 on September 12, 2011 2
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... York College, and one of the most prolific inventors ... that are transmitted from Smartphones to third party agencies. ... and has one of the earliest known patents in ... usage in the military, child care, elder care and ...
(Date:11/21/2014)... REDMOND, Wash. , Nov. 20, 2014 ... access for the Internet of Things (IoT), today announced ... position of chief operating officer. Previously a strategic advisor ... marketing, finance, and operations. Mr. Traynor is based out ... . He reports to Chris Muench , ...
(Date:11/18/2014)... 2014  The Secure Identity & Biometrics Association ... announce the formation of The Airport Entry and ... Identity and Biometric Entry and Exit Solutions Framework ... support from BORDERPOL, the international non-profit organization that ... expertise regarding border security, traveler and migration systems. ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... , June 24, 2013 /PRNewswire-iReach/ -- TabletKiosk®, a ... for business, today announces a new collaboration with ... tracking, eye control, guidance and registration technology, to ... first Tablet PC with market ready eye tracking ...
... This news release is available in ... tagging (PBT) is an emerging genetic-based fish tagging method that ... to stock identification because the parents, not the offspring, are ... method provides the same information as traditional physical tags but ...
... question, but there is no simple answer. Researchers at ... allow fish to perform their complex movements. Their findings, published ... , could provide insights in evolutionary biology and lead to ... of bio-inspired underwater vehicles. "If we could play God ...
Cached Biology News:TabletKiosk and SMI Collaborate to Produce the Sahara EyeSlate 2TabletKiosk and SMI Collaborate to Produce the Sahara EyeSlate 3It's all in the genes -- including the tracking device 2Northwestern researchers examine mechanical bases for the emergence of undulatory swimmers 2
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rad51, N-terminal...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Biology Products: